Investing Profile

Chris Bischoff


Managing Director at General Catalyst

Photo of Chris Bischoff, Managing Director at General Catalyst

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
General Catalyst Managing Director
$500K - $10.0M
CompanyStageDateRound SizeTotal Raised
Series ASep 2022£15M
Co-investors: Cameron McLain (Giant Ventures)
Series ASep 2022$15M
Co-investors: Kevin Zhang (Upfront Ventures), Ryan Darnell (Max Ventures), Bobby Lo
Seed RoundJul 2022£6.1M
Co-investors: Dominic McGregor, Jacob Haddad
CHARM Therapeutics
Series AJun 2022$50M
Co-investors: Nihal Sinha (F-Prime Capital Partners)
Eleanor Health
Series CApr 2022$50M
Co-investors: Andy Slavitt (Town Hall Ventures), Trevor Price (Town Hall Ventures), David Whelan (Town Hall Ventures)
Series BDec 2021$43M
Series AAug 2021$27M
Co-investors: Zak Kukoff (General Catalyst), Lonne Jaffe (Insight Partners), Phil Boyer (Crosslink Capital)
Sword Health
Series DNov 2021$160M
Series CJun 2021$85M
Co-investors: Vinod Khosla (Khosla Ventures)
Series FSep 2021$60M
Series EJul 2017$70M
Series EMar 2016$100M
Co-investors: Rob Stavis (Bessemer Venture Partners), Charles Birnbaum (Bessemer Venture Partners), Amy Nauiokas (Anthemis Group), Fabrice Grinda (FJ Labs), John Jarve (Sierra Point Ventures), Arvind Purushotham (Citi Ventures), Jason Finger (The Finger Group), Thomas D. Lehrman (Teamworthy Ventures), Andy Dunn (Red Swan Ventures), Sean Park, Alexander Saint-Amand